Searchable abstracts of presentations at key conferences in endocrinology

ea0094oc6.3 | Metabolism, Obesity and Diabetes | SFEBES2023

Sex hormone contribution to sex differences in a mouse model of beta cell endoplasmic reticulum (ER) stress

Gatward Lydia Daniels , Doherty Lucy , Khot Shreya , Gonzalez Dominguez Carolina , Ruent Sigrid , King Aileen

The KINGS mouse harbours a mutant Ins2 which drives beta cell ER stress, however only males develop diabetes. Since diabetes incidence is lower in women and ER stress is implicated in human diabetes, we investigated the influence of oestrogen and testosterone in mediating sex differences in the KINGS mouse. To investigate the influence oestrogen (E2) and testosterone removal on glycaemic control, male (n =4-6) and female (n =9) KINGS mice underwent p...

ea0098c2 | Clinical – Chemo/SSA/Biologics | NANETS2023

Neuroendocrine tumor metastatic to breast: case report and review of the literature

Augusto Urrego Jose , Gonzalez Diaz Marcela , Ernesto Romero-Rojas Alfredo , Strosberg Jonathan , Jimenez Vasquez Paola

Background: We report a case of a patient with an ileocecal neuroendocrine tumor (NET) metastatic to both breasts, for whom the initial clinical presentation was chronic diarrhea Breast metastases were initially suspected by a 68-Gallium DOTANOC PET/CT and were confirmed by histopathology. We also performed a comprehensive (non-systematic) literature review through which we identified 116 cases of NENs metastatic to breast.Methods: Case report and compre...

ea0081oc6.2 | Oral Communications 6: Endocrine-Related Cancer | ECE2022

Translational evidence for splicing factor RBM22 as a novel prognostic biomarker and therapeutic target in prostate cancer

Saez-Martinez Prudencio , Jimenez-Vacas Juan M , Montero-Hidalgo Antonio J , Rosa-Herencia Ana D , Herrero-Aguayo Vicente , Leon-Gonzalez Antonio J , Sanchez-Sanchez Rafael , Gonzalez-Serrano Teresa , Gomez-Gomez Enrique , Gahete Manuel D , Luque Raul M

Prostate cancer (PCa) is one the leading causes of cancer-related deaths among men in developed countries. Therefore, identification of novel molecular and therapeutic approaches to tackle this pathology are urgently needed. In this scenario, our group has recently reported that elements of the cellular machinery controlling alternative splicing processes might be used as potential novel therapeutic tools against PCa and castration-resistant PCa (CRPC). In this context, RBM22 ...

ea0081ep695 | Pituitary and Neuroendocrinology | ECE2022

Epidemiological description of 20 years of experience in the management of insulinomas in a third level hospital

Maricel Rivas Montenegro Alejandra , Ramos Roberto Jose An ez , Belinchon Sergio Santos , Gonzalez Fernandez Laura , Moreno Diego Mun oz , Fernandez Fernandez Elisa , Salas Marcel Sambo , Hualpa Juan Carlos Percovich , Gonzalez Albarran Olga , Garcia Centeno Rogelio

Introduction: Insulinoma, despite its low incidence of 0.4%, it is the most common functioning pancreatic neuroendocrine tumor. Most are benign, solitary and sporadic. Around 10% can be malignant and 5-10% are part of MEN-1. On certain occasions, the differential diagnosis is difficult when there is a history of Diabetes Mellitus (DM). Our objective was to describe clinical-epidemiological data and its diagnostic-therapeutic management.Materials and Meth...

ea0049gp240 | Thyroid Cancer & Thyroid Case Reports | ECE2017

Giant goiter with intrathyroid arteriovenous fistula as a cause of severe pulmonary hypertension

Mesa Elena Marquez , Melo Estefania Gonzalez , Gonzalez Cristina Lorenzo , Marquez Pilar Olvera , Garzon Ricardo Darias , Arranz Maria Teresa Herrera , Bray Bruno Francisco Garcia , Huerta Yolanda Zambrano , Abizanda Enrique Palacio

Introduction: Hyperthyroidism has been described as a rare cause of pulmonary hypertension (PH) as well as systemic arteriovenous fistulas. However, we describe a case of pulmonary hypertension secondary to an intrathyroid arteriovenous fistula, not previously described in the literature.Case report: A 56 year old woman followed in our consultations with multinodular goiter and a long standing hyperthyroidism, secondary to Graves Basedow disease with dif...

ea0035p237 | Clinical case reports Pituitary/Adrenal | ECE2014

Hyperprolactinemia secondary to primary hypothyroidism with hyperplasia pituitary

Centeno Rogelio Garcia , Melero Victor Andia , Fernandez Elisa Fernandez , Salas Marcel Sambo , Gonzalez-Antiguedad Cynthia , de la Camara Marta Motilla , Solis Diego Lezcano , Gonzalez Javier , Rivadeneira Lenin , Requena Maria , Ramirez Maria Laura , Olmedilla Yoko , Arnoriaga Maria

Introduction: Although the most common causes of hyperprolactinemia are prolactinoma and iatrogenic, another possible cause is severe primary hypothyroidism, in which the increase of prolactin is a cause of pituitary stimulation by TRH, and can be presented with pituitary hyperplasia.Case report: A 31-year-old woman who comes to endocrinology clinic for hyperprolactinemia, which was detected by symptoms of amenorrhea–galactorrhea. After normal pregn...

ea0035p445 | Diabetes complications | ECE2014

Autoimmune pancreatitis after intravenous insulin desensitization in a diabetic patient allergic to insulin without pancreatic reserve

Salas Marcel Sambo , Melero Victor Andia , Ishishi Yoko Olmedilla , Centeno Rogelio Garcia , Ramirez Maria Laura , Motilla Marta , Antiguedad Cynthia Gonzalez , Requena Maria , Lopez Javier Gonzalez , Rivadeneira Lenin , Arnoriaga Maria

Introduction: Allergy is an uncommon side-effect of insulin treatment in which desensitization represents an alternative when initial approaches are not effective. Autoimmune pancreatitis (AIP) is an even more rare disease that generally has a successful response to corticosteroids. The case of a 50-year-old diabetic man who developed both processes sequentially is presented.Case report: The patient was admitted for acute diabetes mellitus (DM) decompens...

ea0070aep687 | Pituitary and Neuroendocrinology | ECE2020

Endoscopic transsphenoidal pituitary surgery (ETPS) for pituitary tumors: Outcomes and complications

Venegas-Moreno Eva , Remon Pablo , Dios-Fuentes Elena , Deniz-Garcia Alejandro , Cardenas Eugenio , Kaen Ariel , Martin-Schrader Ignacio , Gonzalez-Rivera Natividad , Roldan Florinda , Cano-Gonzalez David , Soto-Moreno Alfonso

Methods: Restrospective descriptive study of patients who underwent ETPS for pituitary adenoma removal performed by the same surgical team in Virgen del Rocio Hospital of Seville from January 2014 to January 2019.Results: 174 patients had a pituitary adenoma (44 GH, 36 ACTH, 94 Non functioning). 54.02% were female. In acromegaly, 39 (88.63%) patients were operated by ETPS as initial approach. 20 (51.28%) patients had cavernous sinus invation. At outcome ...

ea0081rc13.8 | Rapid Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Gut dysbiosis in patients with cushing’s syndrome in remission. relationship with cardiometabolic risk

Valassi Elena , Manichanh chaysavanh , Martel Duguech Luciana Maria , Gonzalez Fernandez Pedro , Gaztambide Sonia , Puig-Domingo Manel , Webb Youdale Susan

Background: Patients with Cushing’s syndrome (CS) in remission show residual cardiometabolic derangements leading to increased cardiovascular risk. Impaired characteristics of gut microbiome (dysbiosis), such as richness, diversity and composition, have been associated with several cardiometabolic risk factors, including obesity, insulin resistance and atherosclerosis. Whether CS patients present with intestinal dysbiosis is currently unknown. Our study was aimed at evalu...

ea0081p133 | Endocrine-Related Cancer | ECE2022

Rapidly progressive cases of ectopic adrenocorticotropic hormone syndrome

Gonzalez Gracia Lucia , Lopez Gallardo Gema , Oulad Ahmed Bothayna , Dios Fuentes Elena , Beltran Romero Luis , Soto-Moreno Alfonso

Introduction: Adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome (CS) secondary to an ectopic source is an uncommon condition, accounting for 4-5% of all cases of CS and between 9-18% of cases of ACTH-dependent CS. Although numerous malignancies have been associated with ectopic ACTH syndrome (EAS), lung neuroendocrine tumours (NETs) are the most common. Refractory hypokalemia can be the presenting feature in EAS and is seen in up to 80% of cases. We present ...